Effects of propranolol on symptom and endocrine responses to pentagastrin
- 31 October 2004
- journal article
- clinical trial
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 29 (9), 1163-1171
- https://doi.org/10.1016/j.psyneuen.2004.01.009
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Dose Response of Arginine Vasopressin to the CCK-B Agonist PentagastrinNeuropsychopharmacology, 2001
- Dose Response of Adrenocorticotropin and Cortisol to the CCK-B Agonist PentagastrinNeuropsychopharmacology, 1999
- Role of different neurotransmitter systems in the cholecystokinin octapeptide-induced anxiogenic response in ratsNeuropeptides, 1997
- Pentagastrin infusions in patients with panic disorder II. NeuroendocrinologyBiological Psychiatry, 1994
- Pentagastrin infusions in patients with panic disorder I. Symptoms and cardiovascular responsesBiological Psychiatry, 1994
- The Panicogenic Effects of Cholecystokinin-Tetrapeptide Are Antagonized by L-365,260, a Central Cholecystokinin Receptor Antagonist, in Patients With Panic DisorderArchives of General Psychiatry, 1994
- Peripheral adrenergic receptor contributions to cardiovascular reactivity: Influence of race and genderJournal of Psychosomatic Research, 1993
- Enhanced Sensitivity to Cholecystokinin Tetrapeptide in Panic DisorderArchives of General Psychiatry, 1991
- Cholecystokinin-Tetrapeptide Induces Panic Attacks in Patients with Panic DisorderThe Canadian Journal of Psychiatry, 1990
- Abnormal Regulation of Noradrenergic Function in Panic DisordersArchives of General Psychiatry, 1986